Project Updates
Novo Nordisk
Credit: Novo Nordisk
Location: Kalundborg, Denmark
Project type: API Manufacturing Facility
Area: 170,000m²
Estimated Investment: More than DKr42bn ($6bn)
Novo Nordisk announced plans to expand its manufacturing capacity by building a new active pharmaceutical ingredients (API) facility in Kalundborg, Denmark. An investment of more than DKr42bn ($6bn) will be made in the project to enhance capacity throughout the entire global value chain.
IDT
Credit: Dreamsenses Photography
Location: Coralville, Iowa, US
Project type: Therapeutic oligonucleotide manufacturing facility
Area: 41,000ft²
Opening date: October 2023
Integrated DNA Technologies (IDT) opened a therapeutic oligonucleotide manufacturing facility in Coralville, Iowa, US, in October 2023. IDT is a genomics solutions provider that is part of Danaher. The facility supplies good manufacturing practice (cGMP)-grade cell and gene therapy reagents.
Aragen Life Sciences
Credit: Aragen Life Sciences Ltd
Location: Bangalore, India
Project type: Biologics manufacturing facility
Area: 160,000m²
Estimated investment: $30m
Aragen Life Sciences will build its first biologics manufacturing facility in Bangalore, India. The facility will be utilised to develop and manufacture monoclonal antibodies, therapeutic proteins, and fusion proteins, enhancing the company’s existing bioproduction capability in California, US.
